ATLAS Clinical Study

Does Your Skin Itch Due To Atopic Dermatitis?

Consider Participating in this Clinical Study

An Investigational Treatment Option for Atopic Dermatitis

The ATLAS clinical study is testing the benefits and risks of an experimental injectable drug given under the skin (subcutaneous) to treat AD

AD is a skin condition that causes intense itching as well as patches of red bumps, flakes, weepy, or thick, crusty skin across the face, neck, body, and/or arms/legs.

You May Be Eligible If *

You are 18 - 80 years old
Have received a medical diagnosis of moderate-to-severe Atopic Dermatitis (AD) (also known as Atopic Eczema) for at least 3 years
Have tried topical (applied to the skin) treatments for AD, and they have not worked well, or you are unable to use them

Participation Details

Qualified participants will receive medication, lab tests and medical care related to the study at no cost
Participants are eligible for compensation to cover the cost of time and travel

Learn more at www.clinicaltrials.gov – NCT05155085

Learn More

To learn more about this study, email ATLAS.INFO@ALLAKOS.COM

* Other criteria apply, please discuss with the study doctor.